BG107711A - Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence - Google Patents

Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence

Info

Publication number
BG107711A
BG107711A BG107711A BG10771103A BG107711A BG 107711 A BG107711 A BG 107711A BG 107711 A BG107711 A BG 107711A BG 10771103 A BG10771103 A BG 10771103A BG 107711 A BG107711 A BG 107711A
Authority
BG
Bulgaria
Prior art keywords
phenylimino
amino
urinary incontinence
novel
treating urinary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
BG107711A
Other languages
Bulgarian (bg)
English (en)
Inventor
Pascale Pouzet
Franz Esser
Hisato Kitagawa
Kenji Sakai
Ikunobu Muramatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH Co KG filed Critical Boehringer Ingelheim Pharma GmbH Co KG
Publication of BG107711A publication Critical patent/BG107711A/xx
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG107711A 2000-10-14 2003-04-08 Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence Pending BG107711A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10051005 2000-10-14
PCT/EP2001/011764 WO2002032876A2 (de) 2000-10-14 2001-10-11 Neue m-amino-phenylimino-imidazolidin-derivate zur behandlung der harninkontinenz

Publications (1)

Publication Number Publication Date
BG107711A true BG107711A (en) 2004-02-27

Family

ID=7659815

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107711A Pending BG107711A (en) 2000-10-14 2003-04-08 Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence

Country Status (23)

Country Link
EP (1) EP1328517A2 (de)
JP (1) JP2004511547A (de)
KR (1) KR20030046503A (de)
CN (1) CN1471514A (de)
AR (1) AR035923A1 (de)
AU (1) AU2002215943A1 (de)
BG (1) BG107711A (de)
BR (1) BR0114603A (de)
CA (1) CA2425563A1 (de)
CZ (1) CZ20031333A3 (de)
DE (1) DE10150312A1 (de)
EA (1) EA200300460A1 (de)
EC (1) ECSP034517A (de)
EE (1) EE200300177A (de)
HU (1) HUP0302245A3 (de)
IL (1) IL155338A0 (de)
MX (1) MXPA03003162A (de)
NO (1) NO20031697L (de)
PL (1) PL361359A1 (de)
SK (1) SK4342003A3 (de)
WO (1) WO2002032876A2 (de)
YU (1) YU28203A (de)
ZA (1) ZA200302345B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2806811A1 (de) * 1978-02-17 1979-08-23 Boehringer Sohn Ingelheim Neue substituierte 2-phenylimino- imidazolidine, deren saeureadditionssalze, diese enthaltene arzneimittel und verfahren zur herstellung derselben
CA1201066A (en) * 1981-11-20 1986-02-25 Alcon Laboratories, Inc. N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl|-acetamide solutions for lowering intraocular pressure
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz

Also Published As

Publication number Publication date
HUP0302245A3 (en) 2004-01-28
WO2002032876A3 (de) 2002-07-18
HUP0302245A2 (hu) 2003-10-28
BR0114603A (pt) 2003-10-14
NO20031697D0 (no) 2003-04-11
IL155338A0 (en) 2003-11-23
AU2002215943A1 (en) 2002-04-29
ECSP034517A (es) 2003-04-25
SK4342003A3 (en) 2003-10-07
PL361359A1 (en) 2004-10-04
MXPA03003162A (es) 2004-12-06
JP2004511547A (ja) 2004-04-15
EE200300177A (et) 2003-08-15
EP1328517A2 (de) 2003-07-23
CA2425563A1 (en) 2002-04-25
YU28203A (sh) 2006-05-25
ZA200302345B (en) 2004-04-23
KR20030046503A (ko) 2003-06-12
WO2002032876A2 (de) 2002-04-25
CZ20031333A3 (cs) 2003-08-13
DE10150312A1 (de) 2002-07-04
AR035923A1 (es) 2004-07-28
EA200300460A1 (ru) 2004-02-26
CN1471514A (zh) 2004-01-28
NO20031697L (no) 2003-05-26

Similar Documents

Publication Publication Date Title
WO2002057252A3 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
AP2002002637A0 (en) Novel piperazine
EP1465861A4 (de) Alpha-(n-sulfonamid)acetamidderivate als beta-amyloidinhibitoren
EP1527049B8 (de) Kondensierte heterozyklische verbindungen als petidase inhibitoren
WO2001019798A3 (en) Inhibitors of factor xa
CA2379747A1 (en) Novel succinate derivative compounds useful as cysteine protease inhibitors
WO2000071510A3 (en) INHIBITORS OF FACTOR Xa
ES2187473T3 (es) Triarylimidazoles.
NZ518542A (en) Triphenylalkene derivatives and their use as selective estrogen receptor modulators
WO2001019788A3 (en) BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
GEP20074166B (en) Acetyl 2-hydroxy-1,3 diaminoalkanes
ATE248824T1 (de) Substituierte phenylderivate, ihre herstellung und verwendung
BR9706639A (pt) Derivados de tetrahidrofurano tetracíclicos substituídos
TW200503712A (en) (2-carboxamido)(3-amino)thiophene compounds
YU94103A (sh) Novi derivati sulfonske kiseline
YU30603A (sh) Derivati premošćenog piperazina
NZ518637A (en) Bicyclic imidazo-3-yl amine derivatives substituted on the 6-membered ring
WO2003004497A1 (fr) Compose heterocyclique
TNSN05067A1 (en) Acetyl 2-hydroxy- 1,3 diaminoalkanes
AU3853697A (en) N-benzenesulphonyl-l-proline derivatives as bradykinin b2 agonists
BG107711A (en) Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
ATE246177T1 (de) Katecholhydrazon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten
AP2002002595A0 (en) Heterocyclic amide derivatives.
RS50449B (sr) Supstituisani bisindolilmaleimidi za inhibiciju proliferacije ćelija
BG105247A (en) N-substituted azabicycloheptane derivatives, production and use thereof